ArticleMicrobiology spectrum2026
Urine sample for HPV detection in men: is it a valid and non-invasive diagnostic alternative?
Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) represents the most prevalent sexually transmitted infection worldwide, often presenting as asymptomatic or subclinical in males. There is still uncertainty about the most suitable biological specimen for an accurate HPV diagnosis in males since the sampling site influences the performance of the diagnosis. Conventional diagnostic strategies rely on uncomfortable specimens for patients, such as urethral swabs. This study aimed to evaluate the diagnostic performance of using non-invasive, self-collected urine samples as an alternative to urethral swabs for detecting HPV infections in men. A total of 110 men provided a genital swab, a urethral swab, and a urine sample for analysis. HPV DNA was detected in 74.5% of the total samples, with 89.0% of HPV-positive samples harboring at least one oncogenic genotype. The most frequently detected genotypes were HPV53, HPV66, and HPV16. Of the individual specimens examined, genital swabs demonstrated the highest HPV positivity rate (68.2%), significantly outperforming urethral swabs and urine samples (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.